A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : AR / adverse reactions

[Related PubMed/MEDLINE]
Total Number of Papers: 41
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   AR  (>> Co-occurring Abbreviation)
Long Form:   adverse reactions
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2019 Adjuvant treatment with Xiaoqinglong formula for bronchial asthma: Protocol of systematic review and meta-analysis. CBM, CNKI, ER, XQLD
2019 FDA Approval Summary: Ivosidenib for Relapsed or Refractory Acute Myeloid Leukemia with an Isocitrate Dehydrogenase-1 Mutation. CI, CR, CRh, IDH, TD, TI
2019 Low-dose cyclosporine for active lupus nephritis: a dose titration approach. CR, LN
2019 Safety of complementary and alternative medicine in children: A 16-years retrospective analysis of the Italian Phytovigilance system database. CAM
2019 Study of serious adverse drug reactions using FDA-approved drug labeling and MedDRA. ADRs, BW, HCA, MedDRA, NDA, PTs, SADRs, WP
2018 Immunogenicity of branched polyethylene glycol modified interferon alpha. ATA, NAb, SVR24
2017 A modified multiparametric assay using HepaRG cells for predicting the degree of drug-induced liver injury risk. BW, DILI, FDA, ROC-AUC, WDN, WP
2016 Hemovigilance survey of pathogen-reduced blood components in the Warsaw Region in the 2009 to 2013 period. IHTM, M-PCs, PRT, RBTCW
2016 Use of herbal remedies by multiple sclerosis patients: a nation-wide survey in Italy. CAM, HR, MS
10  2014 A comparison of two non-thrust mobilization techniques applied to the C7 segment in patients with restricted and painful cervical rotation. ---
11  2014 Identifying high-risk medication: a systematic literature review. ME, NSAIDS
12  2013 Adverse reactions to cosmetic products and the Notification System in Health Surveillance: a survey. ---
13  2013 Antipsychotics and seizures: higher risk with atypicals? FGA, ROR, SGA
14  2013 Evaluating standard terminologies for encoding allergy information. MedDRA, NDF-RT, SNOMED CT, UNII
15  2013 Nifurtimox therapy for Chagas disease does not cause hypersensitivity reactions in patients with such previous adverse reactions during benznidazole treatment. HR
16  2013 The safety profile of perflutren microsphere contrast echocardiography during rest and stress imaging: results from an Australian multicentre cohort. CEE
17  2012 Anticoagulation in large-volume leukapheresis: comparison between citrate- versus heparin-based anticoagulation on safety and CD34 (+) cell collection efficiency. LVL, PBPC, SDF
18  2012 Benefit-risk analysis of glatiramer acetate for relapsing-remitting and clinically isolated syndrome multiple sclerosis. BR, CIS, GA, IFNs, MS, RR, RRMS, WHO
19  2012 Study of biomaterial-induced macrophage activation, cell-mediated immune response and molecular oxidative damage in patients with dermal bioimplants. MPO
20  2012 [Assessing adverse reactions in clinical trials]. ---
21  2012 [The efficiency and safety of adalimumab treatment in patients with active rheumatoid arthritis unresponsive to standard therapy: Russian national study results]. ADA, CRP, RA
22  2011 Disease-specific adverse events following nonlive vaccines: a paradoxical placebo effect or a nocebo phenomenon? AEFIs, qHPV, ROR
23  2010 Adverse reactions to antituberculosis drugs in in-hospital patients: Severity and risk factors. CI, RR, TB
24  2010 Pharmacovigilance of psychoactive medications in a Mexican psychiatric hospital. MMR
25  2010 [Frequency of adverse reactions after influenza vaccination in health care personnel of a university hospital in Spain]. ---
26  2010 [The efficacy and safety of infliximab in patients with ankylosing spondylitis: results of an open-labeled multicenter study]. AS, BASDAI, BASFI
27  2008 Rabies post-exposure prophylaxis in the Philippines: health status of patients having received purified equine F(ab')(2) fragment rabies immunoglobulin (Favirab). pERIG, RIG
28  2008 Standardized protocol to identify high-risk patients undergoing therapeutic apheresis procedures. ECV, TA, TBV
29  2008 [Adverse reactions to skin tests and immunotherapy in the practice of Mexican allergologists]. CMICA, IT, ST
30  2006 Safety assessment of intensive induction with vincristine, ifosfamide, doxorubicin, and etoposide (VIDE) in the treatment of Ewing tumors in the EURO-E.W.I.N.G. 99 clinical trial. ET, G-CSF, GFR, VIDE
31  2006 [Safety of venom immunotherapy in patients pretreated with antihistamines--a retrospective study]. ---
32  2005 Retrospective study of tolerance to short initiation schedules in subcutaneous immunotherapy. ---
33  2003 The pharmacovigilance of psychoactive medications in Brazil. ---
34  2003 [Prevention of adverse reactions of antituberculous drugs in pulmonary tuberculosis in patients with different genetic background]. ---
35  2001 [Causes and countermeasures about adverse reaction of traditional Chinese medicine]. ---
36  1996 [Drug surveillance and adverse reactions to drugs. The literature and importance of historical data]. ---
37  1994 [Adverse reactions from angiotensin-converting enzyme inhibitor drugs reported by the yellow card]. CP, DDD, EN, YC
38  1993 [Scintigraphy of myocardial perfusion combined with pharmacologic stress with dipyridamole]. AP, CAD, HR, SD, TS, VD
39  1992 [Adverse reactions to natural remedies]. ---
40  1990 Large-scale open trials with etodolac (Lodine) in France: an assessment of safety. AS, NSAID, OA, RA
41  1979 Furosemide-induced adverse reactions in cirrhosis of the liver. ---